1. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver. Cancer. 1999. 85:562–582.
Article
2. Kim BJ, Lee KT, Lee JH, Lee JK, Koh KC, Paik SW, Rhee JC, Lim JH, Park CK. Clinical characteristics of hepatic epithelioid hemangioendothelioma. Korean J Gastroenterol. 2002. 40:181–185.
3. Klippel JK, Crofford LJ, Stone JH, Weyand CM. Primer on the rheumatic diseases. 2001. 12th ed. Atlanta: Arthritis foundation;493–495.
4. Uchimura K, Nakamuta M, Osoegawa M, Takeaki S, Nishi H, Iwamoto H, Enjoji M, Nawata H. Hepatic epithelioid hemangioendothelioma. J Clin Gastroenterol. 2001. 32:431–434.
Article
5. Vazquez-Abad D, Martinez-Lavin M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol. 1991. 9:59–62.
6. Matucci-Cerinic M, Martinez-Lavin M, Rojo F, Fonseca C, Kahaleh BM. Von Willebrand factor antigen in hypertrophic osteoarthropathy. J Rheumatol. 1992. 19:765–767.
7. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptor. FASEB J. 1999. 13:9–22.
8. Silveira L, Martinez-Lavin M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol. 2000. 18:57–62.
9. Taege C, Holzhausen H, Gunter G, Flemming P, Rodeck B, Rath FW. Malignant epithelioide hemangioendothelioma of the liver: a very rare tumor in children. Pathologe. 1999. 20:345–350.
10. Szymik-Kantorowicz S, Partyka L, Dembinska-Kiec A, Zdzienicka A. Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Med Pediatr Oncol. 2003. 40:196–197.
Article
11. Zufferey P, Goycochea M, Grossin M, M'Bappe P, Meyer O, Kahn MF. Ostéoarthropathie hypertrophiante révélatrice d'un hémangioendothélioma épithélioïde multifocal hépatique et pulmonaire. Rev Rhum Ed Fr. 1993. 60:928–931.
12. Ledson MJ, Convery R, Carty A, Evans CC. Epithelioid haemangioendothelioma. Thorax. 1999. 54:560–561.
Article